β-Catenin Signaling Mechanisms in Development and Cancer

β-Catenin is a multifunctional protein that coordinates cell–cell adhesion and gene transcription. In its adhesive role, β-catenin binds to cadherin receptors at adherens junctions, stabilising tissue architecture during embryogenesis and organ morphogenesis. In the canonical Wnt pathway, extracellular Wnt ligands engage Frizzled and LRP co-receptors, leading to inhibition of a cytoplasmic “destruction complex” composed of APC, Axin and GSK3. This stabilises cytosolic β-catenin, which then translocates to the nucleus to act as a co-activator of TCF/LEF transcription factors. Through this mechanism, β-catenin controls the proliferation, fate determination and patterning of progenitor cells across diverse tissues.

During normal development, tight regulation of β-catenin ensures correct spatial and temporal gene expression. Dysregulation arises when mutations in CTNNB1 or alterations in the destruction complex lead to aberrant β-catenin accumulation. Such hyperactivation underpins numerous cancers by driving uncontrolled cell division, inhibiting differentiation and promoting tumour-associated programmes such as angiogenesis and immune evasion.

Therapeutic targeting of β-catenin signalling in oncology has pursued restoration of the destruction complex, small-molecule inhibitors of nuclear translocation and blockade of critical phosphorylation events. However, the pleiotropic roles of β-catenin in normal tissues necessitate highly selective strategies to avoid impairing essential developmental and homeostatic functions.

Research from Nature Portfolio

No recent Nature Portfolio content available.

β-Catenin Signaling Mechanisms in Development and Cancer publication trend

The graph below shows the total number of articles in β-catenin signaling mechanisms in development and cancer across all publications each year (not limited to Nature Index journals).

Technical terms

Canonical Wnt pathway: A signalling cascade in which Wnt ligands inhibit β-catenin degradation, enabling its nuclear transcriptional activity.

Destruction complex: A cytosolic assembly of proteins (APC, Axin, GSK3) that phosphorylates β-catenin to target it for proteasomal degradation.

Adherens junction: A cell–cell adhesion structure where cadherin receptors link adjacent cells via β-catenin and α-catenin to the actin cytoskeleton.

Phosphorylation: The enzymatic addition of phosphate groups to serine/threonine residues of β-catenin, dictating its stability and localisation.

TCF/LEF transcription factors: Nuclear DNA-binding proteins that recruit β-catenin to regulate gene expression in response to Wnt signalling.

CTNNB1 exon 3 mutations: Genetic alterations that disrupt key phosphorylation sites in β-catenin’s N-terminus, preventing its degradation and driving oncogenic transcription.

References

1. Unique Splicing of Lrp5 in the Brain: A New Player in Neurodevelopment and Brain Maturation. International Journal of Molecular Sciences (2024).
2. Tumor-Promoting Role of GNA14 in Colon Cancer Development. Cancers (2023).
3. Exon 3 mutations of CTNNB1 drive tumorigenesis: a review. Oncotarget (2017).
4. Walking the tight wire between cell adhesion and WNT signalling: a balancing act for β-catenin. Open Biology (2020).